A

Alliance Pharma PLC
LSE:APH

Watchlist Manager
Alliance Pharma PLC
LSE:APH
Watchlist
Price: 64.7 GBX Market Closed
Market Cap: 349.7m GBX

Wall Street
Price Targets

APH Price Targets Summary
Alliance Pharma PLC

Wall Street analysts forecast APH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APH is 67.61 GBX with a low forecast of 62.62 GBX and a high forecast of 89.25 GBX.

Lowest
Price Target
62.62 GBX
3% Downside
Average
Price Target
67.61 GBX
4% Upside
Highest
Price Target
89.25 GBX
38% Upside
Alliance Pharma PLC Competitors:
Price Targets
AHEALTH
Apex Healthcare Bhd
30% Upside
128940
Hanmi Pharm Co Ltd
23% Upside
LUPIN
Lupin Ltd
15% Upside
570
China Traditional Chinese Medicine Holdings Co Ltd
20% Downside
AETHER
Aether Industries Ltd
45% Upside
300558
Betta Pharmaceuticals Co Ltd
6% Upside
FAE
Faes Farma SA
9% Upside
512
Grand Pharmaceutical Group Ltd
26% Downside

Revenue
Forecast

Revenue Estimate
Alliance Pharma PLC

For the last 8 years the compound annual growth rate for Alliance Pharma PLC's revenue is 8%. The projected CAGR for the next 3 years is 9%.

8%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Alliance Pharma PLC

For the last 8 years the compound annual growth rate for Alliance Pharma PLC's operating income is 4%. The projected CAGR for the next 3 years is 16%.

4%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Net Income
Forecast

Net Income Estimate
Alliance Pharma PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is APH's stock price target?
Price Target
67.61 GBX

According to Wall Street analysts, the average 1-year price target for APH is 67.61 GBX with a low forecast of 62.62 GBX and a high forecast of 89.25 GBX.

What is Alliance Pharma PLC's Revenue forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Alliance Pharma PLC's revenue is 8%. The projected CAGR for the next 3 years is 9%.

What is Alliance Pharma PLC's Operating Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Alliance Pharma PLC's operating income is 4%. The projected CAGR for the next 3 years is 16%.

Back to Top